Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Working Capital Changes (2019 - 2023)

Historic Other Working Capital Changes for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $13.6 million.

  • ADC Therapeutics' Other Working Capital Changes rose 1894.26% to $13.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $7.4 million, marking a year-over-year decrease of 3552.86%. This contributed to the annual value of -$6.9 million for FY2024, which is 19369.5% down from last year.
  • According to the latest figures from Q4 2023, ADC Therapeutics' Other Working Capital Changes is $13.6 million, which was up 1894.26% from -$1.3 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Other Working Capital Changes registered a high of $13.6 million during Q4 2023, and its lowest value of -$4.3 million during Q2 2023.
  • For the 5-year period, ADC Therapeutics' Other Working Capital Changes averaged around $1.4 million, with its median value being -$1759.0 (2021).
  • As far as peak fluctuations go, ADC Therapeutics' Other Working Capital Changes surged by 38724998.31% in 2022, and later plummeted by 8827359.11% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Other Working Capital Changes stood at $1804.0 in 2019, then soared by 79168.29% to $1.4 million in 2020, then plummeted by 100.21% to -$2961.0 in 2021, then skyrocketed by 387249.98% to $11.5 million in 2022, then increased by 18.94% to $13.6 million in 2023.
  • Its Other Working Capital Changes stands at $13.6 million for Q4 2023, versus -$1.3 million for Q3 2023 and -$4.3 million for Q2 2023.